Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Viking Therapeutics Inc CVS Health Corp Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Pharmaceuticals Oil and Gas Market Outlook
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Paramount Global Alzheimer's disease Electric vehicles
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Business News Health care industry Science
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Eli Lilly and Co Exchange/traded funds ETF Edge
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Health & Science Biotech and Pharmaceuticals Gilead Sciences Inc
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Stock Picks Eli Lilly and Co THE JM SMUCKDRN
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Europe News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Pharmaceuticals Business Companies
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Eli Lilly and Co Business News Health care industry
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Social issues Novo Nordisk A/S Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Eli Lilly and Co CNBC Changemakers Novo Nordisk A/S
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Stock markets Mad Money Investment strategy
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Eli Lilly and Co Business News Health care industry
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Eli Lilly and Co NVIDIA Corp Oracle Corp
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Health care industry Science Eli Lilly and Co
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Alphabet Inc Breaking News: Technology Technology
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Technology Eli Lilly and Co Alphabet Inc
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health insurance Small Business Small Business Playbook
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Novo Nordisk A/S Eli Lilly and Co Business News
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags U/S/ Markets Personal investing AI / Artificial Intelligence
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Goldman Sachs Group Inc Health care industry Mobile
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Business Business News Health care industry
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Investment Strategy Arista Networks Inc Sony Group Corp
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Bristol/Myers Squibb Co Investment strategy Investing
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Companies Business Roche Holding AG
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Novo Nordisk A/S Social issues Eli Lilly and Co
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Eli Lilly and Co Novo Nordisk A/S Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.